Confronting Covid-19 by exploring the possibility of vaccinating with live SARS-CoV-2 virus itself, via a route that would reduce the incidence of pulmonary complications.

Joly E

Open source

DOI
10.12688/f1000research.23480.1
Published
2020
Container
F1000Research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.12688/f1000research.23480.1,
  title = {Confronting Covid-19 by exploring the possibility of vaccinating with live SARS-CoV-2 virus itself, via a route that would reduce the incidence of pulmonary complications.},
  author = {Joly E},
  year = {2020},
  journal = {F1000Research},
  doi = {10.12688/f1000research.23480.1},
  url = {https://doi.org/10.12688/f1000research.23480.1}
}

RIS

TY  - JOUR
TI  - Confronting Covid-19 by exploring the possibility of vaccinating with live SARS-CoV-2 virus itself, via a route that would reduce the incidence of pulmonary complications.
AU  - Joly E
PY  - 2020
JO  - F1000Research
DO  - 10.12688/f1000research.23480.1
UR  - https://doi.org/10.12688/f1000research.23480.1
ER  - 

APA

E, J. (2020). Confronting Covid-19 by exploring the possibility of vaccinating with live SARS-CoV-2 virus itself, via a route that would reduce the incidence of pulmonary complications.. F1000Research. https://doi.org/10.12688/f1000research.23480.1

Source records